CrushSCI.com
51.4平均天数
34中位天数
3最短天数
236最长天数
3842025发文量

Paper Review Records

全部论文审稿周期

30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

10 天

Heritability of Transcranial Doppler Velocity in Sickle Cell Anemia Across Two Independent Pediatric Cohorts

作者
Guolian Kang; Clifford M. Takemoto; Mitchell J. Weiss; Parul Rai; Deepa Manwani; Sara R. Rashkin; Chengzhou Wu; Michael R. DeBaun展开收起
作者单位
1. Department of Biostatistics St. Jude Children's Research Hospital Memphis Tennessee USA; 2. Department of Hematology St. Jude Children's Research Hospital Memphis Tennessee USA; 3. Department of Pediatrics Vanderbilt University Medical School Nashville Tennessee USA展开收起
PDF源文件 DOI 网页
6 天

Longevity in Thalassemia: Which Clock Are We Trying to Slow?

作者
Khaled M. Musallam; Shahrukh Hashmi; Mohamed Al Ameri; Ayman W. El‐Hattab; Ali T. Taher展开收起
作者单位
1. Center for Research on Rare Blood Disorders (CR‐RBD) and Thalassemia & Sickle Cell Center Burjeel Cancer Institute, Burjeel Medical City Abu Dhabi UAE; 2. Department of Public Health & Epidemiology College of Medicine and Health Sciences, Khalifa University Abu Dhabi UAE; 3. Division of Hematology/Oncology, Department of Pediatrics Weill Cornell Medicine New York New York USA; 4. Department of Health, Health Life Sciences Abu Dhabi UAE; 5. Department of Biology and Life Sciences Mohamed Bin Zayed University of Artificial Intelligence Abu Dhabi UAE; 6. Department of Biomedical Sciences College of Medicine and Health Sciences, Khalifa University Abu Dhabi UAE; 7. Genetics and Rare Disease Center, Burjeel Cancer Institute, Burjeel Medical City Abu Dhabi UAE; 8. Department of Medical Sciences College of Medicine and Health Sciences, Khalifa University Abu Dhabi UAE; 9. Department of Internal Medicine American University of Beirut Medical Center Beirut Lebanon展开收起
PDF源文件 DOI 网页
83 天

Outcomes of Patients With AL Amyloidosis and End‐Stage Renal Disease After Initiation of Therapy

作者
Foteini Theodorakakou; Lilli Sophie Sester; Ute Hegenbart; Paolo Milani; Claudia Bellofiore; Erasmia Psimenou; Charikleia Gakiopoulou; Meletios A. Dimopoulos; Giovanni Palladini; Stefan O. Schönland; Efstathios Kastritis展开收起
作者单位
1. Department of Clinical Therapeutics National and Kapodistrian University of Athens, School of Medicine Athens Greece; 2. Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Amyloidosis Center University Hospital Heidelberg Heidelberg Germany; 3. Department of Molecular Medicine University of Pavia Pavia Italy; 4. Amyloidosis Research and Treatment Center Fondazione IRCCS Policlinico San Matteo Pavia Italy; 5. First Department of Pathology National and Kapodistrian University of Athens Athens Greece; 6. Department of Medicine Korea University Seoul South Korea展开收起
PDF源文件 DOI 网页
8 天

Voxelotor in Children With Conditional Cerebral Blood Flow Velocity: What HOPE Kids 2 Teaches Us About Efficacy, Mortality, and Malaria Risk in Africa

作者
Jeffrey G. Edwards; Julie Makani; Natasha M. Archer展开收起
作者单位
1. Department of Global Pediatric Medicine St. Jude Children's Research Hospital Memphis Tennessee USA; 2. Muhimbili University of Health and Allied Sciences Dar es Salaam Tanzania; 3. Boston Children's Hospital Dana‐Farber Cancer Institute Boston Massachusetts USA展开收起
PDF源文件 DOI 网页
5 天

Current Treatment Landscape and Advances in Lymphoma in China: A Special Issue

作者
Yuqin Song展开收起
作者单位
1. Department of Lymphoma Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute Beijing China展开收起
PDF源文件 DOI 网页
154 天

Development and Validation of a Novel Geriatric Risk Score for Prognostication in Older Patients With Hodgkin Lymphoma: A Multicenter Retrospective Study

作者
Peiqi Zhao; Yihan Wang; Min Bai; Chen Huang; Jiesong Wang; Yajun Li; Yanan Jiang; Ganggang Wang; Feng Zhu; Shu Zhao; Wei Guo; Shukai Qiao; Jianxia He; Ji Ma; Yanyan Zhang; Lei Zhu; Li Li; Wenyue Yu; Shaozhen Chen; Junqing Xu; Ou Bai; Hui Zhou; Qingyuan Zhang; Liping Su; Yuanlin Xu; Huilai Zhang展开收起
作者单位
1. Department of Lymphoma Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin Medical University Tianjin China; 2. Department of Internal Medicine Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou China; 3. Department of Hematology Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University Taiyuan China; 4. Department of Hematology The Fourth Hospital of Hebei Medical University Shijiazhuang China; 5. Department of Lymphoma & Head and Neck Oncology, College of Clinical Medicine for Oncology Fujian Medical University Fuzhou China; 6. Department of Lymphoma and Hematology The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital Changsha China; 7. Department of Hematology Yantai Yuhuangding Hospital Affiliated to Qingdao University Yantai China; 8. Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital Taiyuan China; 9. Department of Hematology The Affiliated Hospital of Xuzhou Medical University Xuzhou China; 10. Department of Medical Oncology Harbin Medical University Cancer Hospital, Harbin Medical University Harbin China; 11. Department of Hematology The First Hospital of Jilin University Changchun China; 12. Department of Hematology The Second Hospital of Hebei Medical University Shijiazhuang China; 13. Department of Hematology Shanxi Provincial People's Hospital Taiyuan China; 14. Department of Hematology, Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan China; 15. Nanjing Geneseeq Technology Inc. Nanjing China; 16. Department of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital Tianjin Medical University Tianjin China; 17. Clinical Pathology Department, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital Taiyuan China; 18. Cancer Research Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei China展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。